Influenza virus infects bone marrow mesenchymal stromal cells in vitro: Implications for bone marrow transplantation

Cell Transplantation

Volumn 22, Issue 3, 2013, Pages 461-468

  Khatri, Mahesh ^a   Saif, Yehia M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Cell therapy; Influenza virus; Mesenchymal stromal cells (MSCs)

Indexed keywords

BETA1 INTEGRIN; HERMES ANTIGEN; INTERLEUKIN 6; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 1; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL ISOLATION; CYTOKINE PRODUCTION; CYTOLYSIS; EXPERIMENTAL PIG; FEMALE; IN VITRO STUDY; INFECTION SENSITIVITY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MESENCHYMAL STROMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERLEUKIN-6; MESENCHYMAL STROMAL CELLS; RECEPTORS, CELL SURFACE; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877274954     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X656063     Document Type: Article

References (49)

1. Awad, H. A.; Boivin, G. P.; Dressler, M. R.; Smith, F. N.; Young, R. G.; Butler, D. L. Repair of patellar tendon injuries using a cell-collagen composite. J. Orthop. Res. 21:420-431; 2003.
2. Bastos, D. A.; Rodrigues, C. A.; Patah, P.; Kallas, E. G.; Rocha, V.; Novis, Y. Pandemic influenza A H1N1/09 virus infection in hematopoietic SCT recipient. Bone Marrow Transplant. 46:467-468; 2011.
3. Bosch, P.; Pratt, S. L.; Stice, S. L. Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol. Reprod. 74:46-57; 2006.
4. Cheung, C. Y.; Poon, L. L.; Lau, A. S.; Luk, W.; Lau, Y. L.; Shortridge, K. F.; Gordon, S.; Guan, Y.; Peiris, J. S. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: A mechanism for the unusual severity of human disease? Lancet 360:1831-1837; 2002.
5. Choi, S. M.; Boudreault, A. A.; Xie, H.; Englund, J. A.; Corey, L.; Boeckh, M. Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 117:5050-5056; 2011.
6. Claas, E. C.; Osterhaus, A. D.; van Beek, R.; De Jong, J. C.; Rimmelzwaan, G. F.; Senne, D. A.; Krauss, S.; Shortridge, K. F.; Webster, R. G. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477; 1998.
7. Crapnell, K. B.; Almeida-Porada, G.; Khaiboullina, S.; St. Jeor, S. C.; Zanjani, E. D. Human haematopoietic stem cells that mediate long-term in vivo engraftment are not susceptible to infection by human cytomegalovirus. Br. J. Haematol. 124:676-684; 2004.
8. Djouad, F.; Charbonnier, L. M.; Bouffi, C.; Louis-Plence, P.; Bony, C.; Apparailly, F.; Cantos, C.; Jorgensen, C.; Noel, D. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025-2032; 2007.
9. Espinosa-Aguilar, L.; Green, J. S.; Forrest, G. N.; Ball, E. D.; Maziarz, R. T.; Strasfeld, L.; Taplitz, R. A. Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: Two centers' experiences. Biol. Blood Marrow Transplant. 17:566-573; 2011.
10. Gao, J.; Dennis, J. E.; Muzic, R. F.; Lundberg, M.; Caplan, A. I. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169:12-20; 2001.
11. George, B.; Ferguson, P.; Kerridge, I.; Gilroy, N.; Gottlieb, D.; Hertzberg, M. The clinical impact of infection with swine flu (H1N109) strain of influenza virus in hematopoietic stem cell transplant recipients. Biol. Blood Marrow Transplant. 17:147-153; 2011.
12. Go, Y. M.; Kang, S. M.; Roede, J. R.; Orr, M.; Jones, D. P. Increased inflammatory signaling and lethality of influenza H1N1 by nuclear thioredoxin-1. PLoS One 6:e18918; 2011.
13. Guan, Y.; Vijaykrishna, D.; Bahl, J.; Zhu, H.; Wang, J.; Smith, G. J. The emergence of pandemic influenza viruses. Protein Cell 1:9-13; 2010
14. Haynesworth, S. E.; Baber, M. A.; Caplan, A. I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1c. J. Cell. Physiol. 166:585-592; 1996.
15. Iyer, S. S.; Rojas, M. Anti-inflammatory effects of mesenchymal stem cells: Novel concept for future therapies. Expert Opin. Biol. Ther. 8:569-581; 2008.
16. Jiang, Y.; Jahagirdar, B. N.; Reinhardt, R. L.; Schwartz, R. E.; Keene, C. D.; Ortiz-Gonzalez, X. R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W. C.; Largaespada, D. A.; Verfaillie, C. M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49; 2002.
17. Khatri, M.; Dwivedi, V.; Krakowka, S.; Manickam, C.; Ali, A.; Wang, L.; Qin, Z.; Renukaradhya, G. J.; Lee, C. W. Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: A potential animal model for human H1N1 influenza virus. J. Virol. 84:11210-11218; 2010.
18. Khatri, M.; O'Brien, T. D.; Goyal, S. M.; Sharma, J. M. Isolation and characterization of chicken lung mesenchymal stromal cells and their susceptibility to avian influenza virus. Dev. Comp. Immunol. 34:474-479; 2010.
19. Khatri, M.; O'Brien, T. D.; Sharma, J. M. Isolation and differentiation of chicken mesenchymal stem cells from bone marrow. Stem Cells Dev. 18:1485-1492; 2009.
20. Khatri, M.; Sharma, J. M. Susceptibility of chicken mesenchymal stem cells to infectious bursal disease virus. J. Virol. Methods 160:197-199; 2009.
21. Kim, S.; Kim, J. H.; Lee, E.; Jeong, Y. W.; Hossein, M. S.; Park, S. M.; Park, S. W.; Lee, J. Y.; Jeong, Y. I.; Kim, H. S.; Kim, Y. W.; Hyun, S. H.; Hwang, W. S. Establishment and characterization of embryonic stem-like cells from porcine somatic cell nuclear transfer blastocysts. Zygote 18:93-101; 2010.
22. Koc, O. N.; Gerson, S. L.; Cooper, B. W.; Dyhouse, S. M.; Haynesworth, S. E.; Caplan, A. I.; Lazarus, H. M. Rapid hematopoietic recovery after coinfusion of autologousblood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 18:307-316; 2000.
23. Kuiken, T.; Taubenberger, J. K. Pathology of human influenza revisited. Vaccine 26 Suppl 4:D59-66; 2008.
24. Lavial, F.; Acloque, H.; Bertocchini, F.; Macleod, D. J.; Boast, S.; Bachelard, E.; Montillet, G.; Thenot, S.; Sang, H. M.; Stern, C. D.; Samarut, J.; Pain, B. The Oct4 homologue PouV and Nanog regulate pluripotency in chicken embryonic stem cells. Development 134:3549-3563; 2007.
25. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Gotherstrom, C.; Hassan, M.; Uzunel, M.; Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441; 2004.
26. Le Blanc, K.; Ringden, O. Mesenchymal stem cells: Properties and role in clinical bone marrow transplantation. Curr. Opin. Immunol. 18:586-591; 2006.
27. Liotta, F.; Angeli, R.; Cosmi, L.; Fili, L.; Manuelli, C.; Frosali, F.; Mazzinghi, B.; Maggi, L.; Pasini, A.; Lisi, V.; Santarlasci, V.; Consoloni, L.; Angelotti, M. L.; Romagnani, P.; Parronchi, P.; Krampera, M.; Maggi, E.; Romagnani, S.; Annunziato, F. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 26:279-289; 2008.
28. Ljungman, P.; Ward, K. N.; Crooks, B. N.; Parker, A.; Martino, R.; Shaw, P. J.; Brinch, L.; Brune, M.; De La Camara, R.; Dekker, A.; Pauksen, K.; Russell, N.; Schwarer, A. P.; Cordonnier, C. Respiratory virus infections after stem cell transplantation: A prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 28:479-484; 2001.
29. Majumdar, M. K.; Thiede, M. A.; Mosca, J. D.; Moorman, M.; Gerson, S. L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J. Cell. Physiol. 176:57-66; 1998.
30. Nichols, W. G.; Guthrie, K. A.; Corey, L.; Boeckh, M. Influenza infections after hematopoietic stem cell transplantation: Risk factors, mortality, and the effect of antiviral therapy. Clin. Infect. Dis. 39:1300-1306; 2004.
31. Noel, D.; Djouad, F.; Jorgense, C. Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr. Opin. Investig. Drugs 3:1000-1004; 2002.
32. Parsons, C. H.; Szomju, B.; Kedes, D. H. Susceptibility of human fetal mesenchymal stem cells to Kaposi sarcomaassociated herpesvirus. Blood 104:2736-2738; 2004.
33. Pelttari, K.; Steck, E.; Richter, W. The use of mesenchymal stem cells for chondrogenesis. Injury 39 Suppl 1:S58-S65; 2008.
34. Pevsner-Fischer, M.; Morad, V.; Cohen-Sfady, M.; Rousso-Noori, L.; Zanin-Zhorov, A.; Cohen, S.; Cohen, I. R.; Zipori, D. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109:1422-1432; 2007.
35. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
36. Pittenger, M. F.; Martin, B. J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95:9-20; 2004.
37. Ren, G.; Su, J.; Zhang, L.; Zhao, X.; Ling, W.; L'Huillie, A.; Zhang, J.; Lu, Y.; Roberts, A. I.; Ji, W.; Zhang, H.; Rabson, A. B.; Shi, Y. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27:1954-1962; 2009.
38. Rollin, R.; Alvarez-Lafuente, R.; Marco, F.; Jover, J. A.; Hernandez-Garcia, C.; Rodriguez-Navas, C.; Lopez-Duran, L.; Fernandez-Gutierrez, B. Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: Analysis with quantitative real-time polymerase chain reaction. Osteoarthritis Cartilage 15:475-478; 2007.
39. Sedger, L. M.; Hou, S.; Osvath, S. R.; Glaccum, M. B.; Peschon, J. J.; van Rooijen, N.; Hyland, L. Bone marrowB cell apoptosis during in vivo influenza virus infectionrequires TNF-TTand lymphotoxin-a. J. Immunol. 169:6193-6201; 2002.
40. Subbarao, K.; Klimov, A.; Katz, J.; Regnery, H.; Lim, W.; Hall, H.; Perdue, M.; Swayne, D.; Bender, C.; Huang, J.; Hemphill, M.; Rowe, T.; Shaw, M.; Xu, X.; Fukuda, K.; Cox, N. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-396; 1998.
41. Suzuki, K.; Okada, H.; Itoh, T.; Tada, T.; Mase, M.; Nakamura, K.; Kubo, M.; Tsukamoto, K. Association of increased pathogenicity of Asian H5N1 highly pathogenic avian influenza viruses in chickens with highly efficient viral replication accompanied by early destruction of innate immune responses. J. Virol. 83:7475-7486; 2009.
42. Szretter, K. J.; Gangappa, S.; Lu, X.; Smith, C.; Shieh, W. J.; Zaki, S. R.; Sambhara, S.; Tumpey, T. M.; Katz, J. M. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol. 81:2736-2744; 2007.
43. To, K. F.; Chan, P. K.; Chan, K. F.; Lee, W. K.; Lam, W. Y.; Wong, K. F.; Tang, N. L.; Tsang, D. N.; Sung, R. Y.; Buckley, T. A.; Tam, J. S.; Cheng, A. F. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J. Med. Virol. 63:242-246; 2001.
44. Tomchuck, S. L.; Zwezdaryk, K. J.; Coffelt, S. B.; Waterman, R. S.; Danka, E. S.; Scandurro, A. B. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26:99-107; 2008.
45. Whimbey, E.; Elting, L. S.; Couch, R. B.; Lo, W.; Williams, L.; Champlin, R. E.; Bodey, G. P. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant. 13:437-440; 1994.
46. Yuan, L.; Ward, L. A.; Rosen, B. I.; To, T. L.; Saif, L. J. Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 70:3075-3083; 1996.
47. Yuen, K. Y.; Chan, P. K.; Peiris, M.; Tsang, D. N.; Que, T. L.; Shortridge, K. F.; Cheung, P. T.; To, W. K.; Ho, E. T.; Sung, R.; Cheng, A. F. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467-471; 1998.
48. Zeng, H.; Goldsmith, C.; Thawatsupha, P.; Chittaganpitch, M.; Waicharoen, S.; Zaki, S.; Tumpey, T. M.; Katz, J. M. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J. Virol. 81:12439-12449; 2007.
49. Zhang, Z.; Zhang, J.; Huang, K.; Li, K. S.; Yuen, K. Y.; Guan, Y.; Chen, H.; Ng, W. F. Systemic infection of avian influenza A virus H5N1 subtype in humans. Hum. Pathol. 40:735-739; 2009.